Wells Fargo & Company Casi Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.48 - $2.79 $2 - $5	2 Added 3.33%	62 $0
Q3 2022 Nov 14, 2022	SELL	$2.36 - $4.69 $35 - $70	-15 Reduced 20.0%	60 $0
Q2 2022 Aug 12, 2022	BUY	$2.85 - $7.1 $213 - $532	75 New	75 $0

Ticker CASI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,606,100
Market Cap $38.4M
Description
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patien...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.